期刊文献+

扶正消积胶囊对晚期非小细胞肺癌化疗患者近期疗效及生活质量的影响 被引量:11

Effect of "Fuzheng Xiaoji capsule" on the short-term curative effect and quality of life of patients with advanced non small cell lung cancer
下载PDF
导出
摘要 目的探讨扶正消积胶囊对晚期非小细胞肺癌(NSCLC)化疗患者近期临床疗效及生活质量的影响。方法将72例晚期NSCLC化疗患者采用随机数字表法分为对照组(n=36)和观察组(n=36),对照组患者采用标准化疗方案治疗,观察组患者在化疗基础上联合口服扶正消积胶囊治疗,治疗4个周期后比较两组患者的近期疗效及生活质量。结果观察组患者的疾病控制率、临床症状改善率及生活质量提高稳定率均明显高于对照组,组间比较差异有统计学意义(P<0.05)。结论扶正消积胶囊能提高晚期非小细胞肺癌(NSCLC)化疗患者的近期疗效,改善其生活质量。 Objective To investigate clinical effect in short term of Fuzheng Xiaoji Capsule and impact of quality of life on advanced non-small cell lung cancer (NSCLC) in patients treated with chemotherapy. Methods Seventy-two cases of patients with chemotherapy of advanced NSCLC were randomly divided into control group (n=36) and observation group (n= 36). The control group were treated with standard chemotherapy, the observation group were treated with Fuzheng Xiaoji Capsule on basis of standard chemotherapy. The clinical effect and quality of life were compared between the two groups after 4 cycles. Results The disease control rate, the clinical symptoms improvement rate and the improvement steady rate of quality of life in observation group were all significantly higher than that of control group (P〈0.05). Conclusion Fuzheng Xiaoji Capsule can increase short-term effect and improve quality of life of advanced NSCLC patients with chemotherapy.
作者 刘杰
出处 《临床医学研究与实践》 2016年第14期105-106,共2页 Clinical Research and Practice
关键词 扶正消积胶囊 非小细胞肺癌 化疗 近期疗效 生活质量 Fuzheng Xiaoji Capsule non-small cell lung cancer chemotherapy short-term effect quality of life
  • 相关文献

参考文献4

二级参考文献51

  • 1骆文斌,吴承玉.肺癌病因病机研究[J].辽宁中医药大学学报,2009,11(3):16-17. 被引量:25
  • 2孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J].CA Cancer J Clin,2011,61 (2) :69 -90.
  • 4Reguart,N. ,Cardona,A. F. ,Rosell,R.. Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer [ J]. Cancer Manag Res,2010,38 ( 2 ) : 143.
  • 5]Therasse, P. , Arbuck, S. G.. New guidelines to evaluate the response to treatment in solid tumors [ J ]. NatCancer Inst,2000,92 (3) :205.
  • 6Owonikoko, T. K. , Ramalingam, S. S. , Belani, C. P.. Maintenance therapy for advanced non-small cell lung cancer:current status, con- troversies, and emerging consensus [ J ]. Clin Cancer Res, 2010,16 (9) :2496.
  • 7Grossi F,Aita M,Follador A. Sequential,alternating,and maintenance consolidation chemotherapy in advanced non-small cell lung cancer:a review of the literature[J].Oncologist(The),2007,(04):451-464.
  • 8Ciuleanu T,Brodowicz T,Zielinski C. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study[J].The Lancet,2009,(9699):1432-1440.
  • 9Brodowicz T,Krzakowski M,Zwitter M. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer.a phase Ⅲ trial[J].Lung Cancer,2006,(02):155-163.doi:10.1016/j.lungcan.2006.01.006.
  • 10Muir V J,Dhillon S. Erlotinib:as maintenance monotherapy in non-small-cell lung cancer[J].BioDrugs,2011,(03):139-146.

共引文献193

同被引文献150

引证文献11

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部